سعر سموفليبيد 20% مستحلب 500 مل للحقن الوريدي 2022

SMOFlipid 20% 500 ml (Fresenius Kabi): a lipid injectable emulsion of soya-bean oil, medium-chain triglycerides, olive oil and fish oil, used as a source of calories and essential fatty acids in parenteral nutrition.

• Source of calories and essential fatty acids for parenteral nutrition in adults and paediatric patients, including term and preterm neonates, when oral or enteral nutrition is not possible, insufficient or contraindicated.Population: Adults and paediatric patients including term and preterm neonatesDailyMed (U.S. National Library of Medicine)

• Adults (>1%): nausea, vomiting, hyperglycaemia, flatulence, pyrexia, abdominal pain, increased triglycerides, hypertension, sepsis, dyspepsia, urinary tract infection, anaemia, device-related infection. Paediatric: anaemia, vomiting, increased GGT, nosocomial infection.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to fish, egg, soybean, peanut or any active or inactive ingredient.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Severe disorders of lipid metabolism with hypertriglyceridaemia (serum triglycerides >1,000 mg/dL).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Clinical decompensation (acute respiratory distress, metabolic acidosis, death) with rapid infusion in neonates and infants; do not exceed 0.75 ml/kg/h.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Parenteral nutrition-associated liver disease and other hepatobiliary disorders; monitor liver tests.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity reactions including anaphylaxis (soybean oil, fish oil, egg phospholipids; soy-peanut cross-reactivity).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Recommended dose not expected to cause major birth defects, miscarriage or other adverse maternal/fetal outcomes; no animal reproduction studies; severe malnutrition in pregnancy carries fetal risk and PN should be considered if needs cannot be met orally/enterally.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not expected to harm a breastfed infant at the recommended dose; no data on presence in milk.International label, same formulation · DailyMed (U.S. National Library of Medicine)